Target intelligence / Profile preview

Magnesium transporter NIPA4 (NIPAL4)

Target
NIPAL4
Molecular classification
Transporter, Membrane protein, Possible membrane receptor
01

Overview

NIPAL4 (Magnesium transporter NIPA4) is a transmembrane protein with nine helices, predominantly expressed in the granular layer of the epidermis. It primarily acts as a magnesium transporter, but also facilitates the transport of other divalent cations. NIPAL4 is central to epidermal lipid metabolism by participating in the synthesis of very long chain fatty acids and the formation/secretion of lamellar bodies, thus maintaining the integrity of the skin barrier. Pathogenic mutations in NIPAL4 are the second most common genetic cause of autosomal recessive congenital ichthyosis (ARCI), leading to abnormal lipid composition and barrier dysfunction characteristic of this disease. There is no clear evidence for approved drugs directly modulating NIPAL4, but molecular and cellular studies suggest that restoring skin lipid homeostasis, e.g., via retinoid mimetics, can partly compensate for its deficiency

Other names
NIPAL4NIPA-like domain containing 4Magnesium transporter NIPA4IchthyinARCI6ICHTHYINICHYNSLC57A6Non-imprinted in Prader-Willi/Angelman syndrome region protein 4
02

Mechanism of action

Not established for drug targeting; ARCI symptoms can be partially ameliorated by retinoid-mimetic treatment, suggesting impact via restoration of epidermal lipid metabolism

03

Biological functions

Magnesium (Mg²⁺) transportTransport of divalent cations (Ba²⁺, Mn²⁺, Sr²⁺, Co²⁺)Epidermal lipid metabolismFormation and secretion of lamellar bodiesIntegrity of skin barrier
04

Disease associations

Autosomal recessive congenital ichthyosis (ARCI)Epidermal barrier dysfunctionDisorders of cornification
05

Safety considerations

No specific safety concerns reported for drug targetingchallenges could include off-target effects impacting magnesium homeostasis and skin barrier function
06

Biomarkers

Mutations of NIPAL4 as diagnostic/selection markers for ARCIExpression level in skin for particular forms of congenital ichthyosis

Beyond the preview

Go deeper on Magnesium transporter NIPA4 (NIPAL4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnesium transporter NIPA4 (NIPAL4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call